Kasinger James R.

Kasinger James R. is listed in filings as General Counsel and Secretary at CRISPR Therapeutics AG-Common Shares. This profile follows SEC Form 4 activity through Jun 2, 2026, including sale activity. Recent filings connect the profile to CRISPR Therapeutics AG-Common Shares (CRSP). The current snapshot covers public activity from Oct 15, 2024 to Jun 2, 2026. Reported amounts are shown as $148.9K to $166.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.